To do this, clinical trials need to use consistent core outcomes. Therefore, HARMONY researchers are running several Delphi Surveys to compile Core Outcome Sets (COS) for specific blood cancers/Hematologic Malignancies. Scroll down and view all Delphi Survey projects below.
What are COS and why do we need help from patients, clinicians, regulators and industry?
Opened 4 February 2021: CLL > . In the pipeline: ALL.